首页> 外国专利> COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME-HEMMER AND EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME-HEMMER AND EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

机译:血管紧张素转化酶-酶和环氧-甾体醛固酮拮抗剂的联合治疗,用于治疗心血管疾病

摘要

Combinations of an ACE inhibitor and an epoxy-steroidal aldosterone receptor antagonist are described for use in treatment of circulatory disorders. Of particular interest are therapies using epoxy-steroidal-type aldosterone receptor antagonist compounds, such as eplerenone, in combination with an angiotensin converting enzyme inhibitor. This co-therapy would be particularly useful to treat congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects such as hyperkalemia.
机译:描述了ACE抑制剂和环氧甾体醛固酮受体拮抗剂的组合用于治疗循环系统疾病。特别令人感兴趣的是使用环氧类固醇型醛固酮受体拮抗剂化合物(例如依普利农)与血管紧张素转化酶抑制剂的组合疗法。这种辅助疗法在治疗充血性心力衰竭同时避免或减少醛固酮拮抗剂引起的副作用(如高钾血症)时特别有用。

著录项

  • 公开/公告号AT310537T

    专利类型

  • 公开/公告日2005-12-15

    原文格式PDF

  • 申请/专利权人 G.D. SEARLE LLC.;

    申请/专利号AT20030019610T

  • 申请日2000-03-03

  • 分类号A61K45/06;A61K31/585;A61P9/00;

  • 国家 AT

  • 入库时间 2022-08-21 21:36:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号